Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma

Conditions:   Esophageal Squamous Cell Carcinoma;   Neoadjuvant Chemoimmunotherapy;   Adjuvant Therapy Intervention:   Drug: Tislelizumab Sponsor:   Guo Xufeng Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials